PerpEquities

Oscar Health, Inc. (OSCR)财务

NYSE · Healthcare · Medical - Healthcare Plans · 员工2,305人 · CEO Mark Thomas Bertolini

股价
$30.37 -1.36%
市值
$78.7亿
企业价值
$42.3亿
最近财报
Q2 '26 2026-08-07提交
下次财报
2026-11-05 EPS预期 -$0.14
营收(TTM)$153亿+42.8% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)4.1%+5.3 百分点 对比去年同期营业利润 $6.24亿
净利润(TTM)$5.51亿+441.6% 对比去年同期税后,含营业外收益
自由现金流(TTM)$43.3亿+260.8% 对比去年同期资本支出 $3860万
稀释EPS(TTM)$1.40+284.2% 对比去年同期最近4个季度之和
净现金$81.2亿+151.0% 对比去年同期现金 + 短期投资 - 债务

估值与关键数据

市值
$78.7亿
EV $42.3亿
营收
$153亿
过去12个月
营收增速
+59%
FY2026年一致预期
净利润率
3.6%
净利润 / 营收,TTM
P/E
17.8×
预期 15.7×(FY2026)
P/S
0.5×
股价 / 营收,TTM
EV / EBITDA
6.7×
TTM
自由现金流
$43.3亿
过去12个月
净利润
$5.51亿
过去12个月
营收预期
$186亿
FY2026年一致预期
盈利
2026-11-05
营收预期 $46.9亿
股息
–
无股息

核心要点

根据披露数据计算,每条结论都附有其依据的数字。

  • 最近财报(2026-08-06):营收超预期1.3%,EPS 超预期173.0%营收$47.9亿,预期$47.3亿(+1.3%);EPS $1.10,预期$0.40(+173.0%)。
  • 营收增长加速:同比70.4%Q2 '26营收$48.8亿,此前四个季度的平均值为30.5%。
  • 营业利润率4.1%(TTM),较去年同期+5.3 百分点营收增长42.8%,营业利润增长567.8%。
  • 资本支出占营收的0.3%(去年为0.3%)最近4个季度投入$3860万(同比+18.2%)。自由现金流$43.3亿,相当于净利润的787.1%。
  • 稀释股数一年内增加23.4%Q2 '26稀释股数3.33亿,一年前为2.7亿。
  • 净现金 $81.2亿现金 + 短期投资 $85.6亿,含租赁债务 $4.32亿;一年前净现金 $32.4亿。

上一季度:Q2 '26

截至2026-06-30的季度。与去年同期及财报发布前的分析师一致预期对比。

本季度与去年同期

Q2 '26去年同期变化
营收$48.8亿$28.6亿+70.4%
毛利率100.0%10.9%+89.1 百分点
营业利润$3.83亿-$2.3亿+266.2%
营业利润率7.8%-8.0%+15.9 百分点
净利润$3.62亿-$2.28亿+258.4%
稀释EPS$1.10-$0.84+231.0%
经营现金流$20.5亿$5.09亿+302.2%
资本支出$1180万$928万+26.8%
自由现金流$20.4亿$5亿+307.3%
R&D$0$0–
股权激励费用$2070万$2410万-14.3%

实际 vs 一致预期

2026-08-06
实际一致预期对比预期
营收$47.9亿$47.3亿+1.3%
EPS(一致预期口径)$1.10$0.40+173.0%

来自2026-08-06发布的Q2 '26财报:营收及分析师预期口径的EPS(通常为调整后),可能与上方报表中的EPS不同。

EPS与一致预期

最近8次财报

营收

收入从何而来,按业务线和地区逐季展示。

营收、营业利润与增速

季度

利润率与成本结构

每一单位营收在各层级还剩多少,成本又花在哪里。

利润率

季度

成本占营收比例

季度

现金流与资本配置

创造了多少现金,用在何处,又有多少回到股东手中。

经营现金流、资本支出、自由现金流

季度

现金用途与经营现金流

财年

最近4个季度

现金流量表
经营现金流
$43.7亿
资本支出
-$3860万
股票回购
$0
股息
$0
收购
$0
债务净发行
$3.48亿
股权激励费用
$7520万
自由现金流
$43.3亿
股东回报 / FCF
-0.0%

股数与EPS

季度,稀释

资产负债表

各季度末的流动性、投资和债务。

现金、投资与债务

季度末

估值与回报

当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。

估值倍数与回报

TTM与过去5个财年
当前5年均值当前处于5年区间的位置
P/E(TTM)17.8×122.2× 5年中的1年122.2× – 122.2×
EV / EBITDA6.7×11.9× 5年中的2年1.3× – 22.4×
EV / 营收0.3×0.1× 5年中的4年0.1× – 0.2×
股价 / FCF1.8×2.8× 5年中的3年1.5× – 3.6×
股价 / 净资产4.5×2.2×0.6× – 3.9×
FCF收益率55.1%19.0%-14.8% – 67.2%
投入资本回报率23.0%-20.7%-39.1% – 2.7%
净资产收益率38.5%-37.2%-68.1% – 2.5%

分析师

一致目标价 $37.43 (+23.2%)
区间 $20.00 – $49.00 · 评级 Hold

强烈买入0
买入4
持有8
卖出1
强烈卖出0

展望

分析师对未来财年的一致预期,以及按当前股价意味着什么。

一致预期

财年营收增速EPS增速按当前股价的P/E分析师(EPS)
FY2026$186亿+59.3%$1.93+214.4%15.7×6
FY2027$209亿+11.9%$2.39+23.4%12.7×6
FY2028$245亿+17.6%$2.89+20.9%10.5×6
FY2029$325亿+32.4%$4.02+39.3%7.6×3
FY2030$375亿+15.4%$4.85+20.6%6.3×2

财务报表

利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。

全部披露项目

Oscar Health, Inc.在近期10-Q / 10-K文件中标记的全部215项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。

项目(SEC标签)最近季度去年同期同比最近财年上一财年同比
Accounts Payable and Accrued Liabilities, Current$5.26亿$5.84亿-10.0%$6.5亿$4.32亿+50.2%
Accounts Receivable, after Allowance for Credit Loss, Current$3.8亿–––––
Accounts Receivable, Allowance for Credit Loss, Current$5530万–––––
Accretion (Amortization) of Discounts and Premiums, Investments$821万$799万+2.7%$2980万$2690万+10.8%
Accrued Investment Income Receivable$4660万$2180万+113.8%$2020万$1980万+2.0%
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment$1.42亿2025-12-31$1.14亿+24.1%$1.42亿$1.14亿+24.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax-$825万$1370万-160.1%$1800万-$183万+1,086.9%
Additional Paid in Capital$43.2亿$39.5亿+9.2%$42.6亿$38.7亿+10.0%
Amortization of Debt Issuance Costs$115万$19.5万+488.7%$163万$77.8万+109.5%
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount64.8万7020万-99.1%4770万3820万+24.6%
Assets$112亿$63.8亿+75.9%$63.3亿$48.4亿+30.7%
Assets, Current$93.7亿$43.1亿+117.3%$46.1亿$28.5亿+62.1%
Assets, Fair Value Disclosure$62.7亿––$27.4亿$25.4亿+7.8%
Assumed Premiums Earned-$67.9万$1560万-104.3%$4660万$2.2亿-78.8%
Benefits, Losses and Expenses$44.9亿$30.9亿+45.2%$121亿$91.2亿+32.6%
Cash and Cash Equivalents, at Carrying Value$40.8亿$26亿+56.8%$27.7亿$15.3亿+81.7%
Cash and Cash Equivalents, Fair Value Disclosure$1.89亿––$4960万$9530万-48.0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$41亿$26.2亿+56.3%$28亿$15.5亿+80.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect-$7.29亿$3.63亿-300.8%$12.5亿-$3.41亿+467.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest$2万-$13万+115.4%$24.8万$68.9万-64.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent$3.49亿-$2.24亿+255.4%-$4.23亿$2230万-1,998.5%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest$3.49亿-$2.24亿+255.4%-$4.23亿$2300万-1,940.5%
Current Federal Tax Expense (Benefit)–––$306万$222万+37.9%
Current Income Tax Expense (Benefit)–––$316万$964万-67.3%
Current State and Local Tax Expense (Benefit)–––$9.7万$742万-98.7%
Current Year Claims and Claims Adjustment Expense$38.7亿$26.1亿+48.1%$103亿$76.1亿+36.0%
Debt Securities, Available-for-sale$60.8亿$27.8亿+118.5%$26.9亿$24.4亿+10.2%
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax$170万$1690万-90.0%$1860万$798万+133.6%
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax$1020万$272万+276.8%$61.5万$983万-93.7%
Debt Securities, Available-for-sale, Amortized Cost$60.9亿$27.7亿+119.9%$26.7亿$24.4亿+9.3%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$7010万$1.06亿-33.8%$8200万$0–
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five$15.3亿$17.3亿-11.1%$13.7亿$18.2亿-24.4%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$44.8亿$9.36亿+378.7%$12.1亿$6.23亿+94.6%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer$1980万$0–$4080万$4770万-14.6%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss$31万$0–$12万$2.5万+380.0%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions2 security0 security–5 security6 security-16.7%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months$33.2亿$7.6亿+336.9%$3.48亿$8.77亿-60.4%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss$992万$272万+265.4%$49.5万$980万-95.0%
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions605 security243 security+149.0%107 security301 security-64.5%
Debt Securities, Available-for-sale, Current$44.8亿$9.38亿+377.5%$12.2亿$6.24亿+94.8%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$6960万$1.07亿-34.9%$8280万$0–
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five$15.3亿$17.4亿-12.0%$13.9亿$18.1亿-23.6%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$44.8亿$9.38亿+377.5%$12.2亿$6.24亿+94.8%
Debt Securities, Available-for-sale, Noncurrent$16亿$18.5亿-13.3%$14.7亿$18.2亿-19.0%
Deferred Federal Income Tax Expense (Benefit)–––$3.8万$7.3万-47.9%
Deferred Income Tax Expense (Benefit)-$153万-$3.6万-4,141.7%$245万-$234万+204.7%
Deferred State and Local Income Tax Expense (Benefit)–––$241万-$241万+200.0%
Deferred Tax Assets, Gross$7.27亿2025-12-31$6.05亿+20.1%$7.27亿$6.05亿+20.1%
Deferred Tax Assets, Net$59万2025-12-31$304万-80.6%$59万$304万-80.6%
Deferred Tax Assets, Net of Valuation Allowance$3020万2025-12-31$1410万+114.2%$3020万$1410万+114.2%
Deferred Tax Assets, Operating Loss Carryforwards$6.24亿2025-12-31$5.25亿+18.9%$6.24亿$5.25亿+18.9%
Deferred Tax Assets, Other$1410万2025-12-31$593万+138.5%$1410万$593万+138.5%
Deferred Tax Assets, Property, Plant and Equipment$02025-12-31$797万-100.0%$0$797万-100.0%
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses$641万2025-12-31$765万-16.2%$641万$765万-16.2%
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost$240万2025-12-31$282万-14.9%$240万$282万-14.9%
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Policyholder Liabilities$3040万2025-12-31$2730万+11.3%$3040万$2730万+11.3%
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve$759万2025-12-31$337万+125.1%$759万$337万+125.1%
Deferred Tax Assets, Valuation Allowance$6.96亿2025-12-31$5.91亿+17.9%$6.96亿$5.91亿+17.9%
Deferred Tax Liabilities, Gross$2960万2025-12-31$1110万+167.7%$2960万$1110万+167.7%
Deferred Tax Liabilities, Investments$907万2025-12-31$513万+76.7%$907万$513万+76.7%

来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。

数据来源

报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

数据截至 2026-11-02